A Bayesian model to predict survival after left ventricular assist device implantation

MK Kanwar, LC Lohmueller, RL Kormos… - JACC: Heart Failure, 2018 - jacc.org
Objectives: This study investigates the use of a Bayesian statistical models to predict survival
at various time points in patients undergoing left ventricular assist device (LVAD) …

Patient selection for destination LVAD therapy: predicting success in the short and long term

A Michaels, J Cowger - Current heart failure reports, 2019 - Springer
Abstract Purpose of Review In this review, we discuss risk assessment of advanced heart
failure (HF) patients as a referral guide for advanced HF therapies, including left ventricular …

Challenges and future directions in left ventricular assist device therapy

MK Kanwar, S Bailey, S Murali - Critical Care Clinics, 2018 - criticalcare.theclinics.com
Challenges and Future Directions in Left Ventricular Assist Device Therapy - Critical Care
Clinics Skip to Main Content Skip to Main Menu Advertisement Critical Care Clinics Log in …

A novel model incorporating pectoralis muscle measures to predict mortality after ventricular assist device implantation

R Cogswell, B Trachtenberg, T Murray, J Schultz… - Journal of cardiac …, 2020 - Elsevier
Background We have previously demonstrated that pectoralis muscle mass and tissue
attenuation obtained on preoperative CT scans were powerful predictors of mortality after left …

Machine learning, artificial intelligence and mechanical circulatory support: A primer for clinicians

MK Kanwar, A Kilic, MR Mehra - The Journal of Heart and Lung …, 2021 - Elsevier
Artificial intelligence (AI) refers to the ability of machines to perform intelligent tasks, and
machine learning (ML) is a subset of AI describing the ability of machines to learn …

Prognostic value of vasoactive-inotropic score following continuous flow left ventricular assist device implantation

J Han, A Pinsino, J Sanchez, H Takayama… - The Journal of Heart and …, 2019 - Elsevier
BACKGROUND The purpose of this study is to evaluate the utility of vasoactive-inotropic
score (VIS) in predicting outcomes after left ventricular assist device (LVAD) implantation …

[HTML][HTML] Trends in utilization, mortality, and resource use after implantation of left ventricular assist devices in the United States

Y Sanaiha, P Downey, R Lyons, A Nsair… - The Journal of Thoracic …, 2021 - Elsevier
Objectives Adoption of implantable left ventricular assist devices has dramatically improved
survival and quality of life in suitable patients with end-stage heart failure. In the era of value …

Risk assessment in patients with a left ventricular assist device across INTERMACS profiles using Bayesian analysis

MK Kanwar, LC Lohmueller, J Teuteberg… - ASAIO …, 2019 - journals.lww.com
Current risk stratification models to predict outcomes after a left ventricular assist device
(LVAD) are limited in scope. We assessed the performance of Bayesian models to stratify …

C-reactive protein levels predict outcomes in continuous-flow left ventricular assist device patients: An INTERMACS analysis

J Batra, LK Truby, EM Defilippis, K Takeda… - ASAIO …, 2021 - journals.lww.com
CRP is an established inflammatory biomarker with prognostic value in patients with chronic
heart failure, yet its role in continuous-flow left ventricular assist device (LVAD) patients is …

Predicting Survival of End-Stage Heart Failure Patients Receiving HeartMate-3: Comparing Machine Learning Methods

RY Loyaga-Rendon, D Acharya, M Jani, S Lee… - ASAIO …, 2024 - journals.lww.com
HeartMate 3 is the only durable left ventricular assist devices (LVAD) currently implanted in
the United States. The purpose of this study was to develop a predictive model for 1 year …